Status
Conditions
Treatments
About
This study employs individualized temperature health risk early warning and risk factor management interventions for stroke, and explores their actual intervention effects. This enables patients to promptly understand their own risk levels and take corresponding protective measures, thereby enhancing the management outcomes and quality of life. The study also promotes the interdisciplinary integration of environmental epidemiology and clinical intervention management, providing new ideas and methodological support for future relevant research.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Aged 40 to 80, with no gender restrictions;
Acute ischemic stroke inpatients within 2 weeks of onset, where the onset time is the time when stroke symptoms appear or the last known normal time of the patient (when it is an onset during sleep or the symptom onset time cannot be accurately obtained due to aphasia, impaired consciousness, etc.); ③ Confirmed diagnosis of ischemic stroke by CT or MRI of the brain within 2 weeks after symptom onset;
Local residents (residing for ≥6 months); ⑤ Patients who voluntarily participate in the study, have high compliance, and can sign the informed consent form;
Exclusion criteria
Patients diagnosed with other cerebrovascular diseases (hemorrhagic stroke, transient ischemic attack, cerebral venous sinus thrombosis, etc.) or non-cerebrovascular diseases;
Known pregnant or lactating women, or those who tested positive on a pregnancy test before cluster randomization;
Patients with other conditions that may affect participation in the trial (e.g., refractory hypertension, severe aphasia, etc.);
Primary purpose
Allocation
Interventional model
Masking
10,184 participants in 4 patient groups
Loading...
Central trial contact
Junwei Hao
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal